within Pharmacolibrary.Drugs.ATC.C;

model C10AB05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 2.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0045000000000000005,
    Tlag           = 60.0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C10AB05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Fenofibrate is a lipid-lowering agent that belongs to the class of fibric acid derivatives. It is used primarily to reduce cholesterol and triglycerides (types of fat) in the blood. It is approved for the treatment of hypercholesterolemia and mixed dyslipidemia, often as an adjunct to diet. Fenofibrate is currently approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after single-dose oral administration of micronized fenofibrate.</p><h4>References</h4><ol><li><p>Kosoglou, T, et al., &amp; Alton, KB (2005). Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. <i>Clinical pharmacokinetics</i> 44(5) 467–494. DOI:<a href=\"https://doi.org/10.2165/00003088-200544050-00002\">10.2165/00003088-200544050-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15871634/\">https://pubmed.ncbi.nlm.nih.gov/15871634</a></p></li><li><p>Yang, Y, et al., &amp; Wang, L (2016). Comparisons of pharmacokinetics and NO-releasing of nitrofibriate and fenofibrate after oral administration in rats. <i>Biomedical chromatography : BMC</i> 30(12) 2003–2008. DOI:<a href=\"https://doi.org/10.1002/bmc.3777\">10.1002/bmc.3777</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27270950/\">https://pubmed.ncbi.nlm.nih.gov/27270950</a></p></li><li><p>Jadhav, NV, et al., &amp; Vavia, PR (2022). Pickering Dry Emulsion System for Improved Oral Delivery of Fenofibrate. <i>AAPS PharmSciTech</i> 23(6) 168–None. DOI:<a href=\"https://doi.org/10.1208/s12249-022-02292-y\">10.1208/s12249-022-02292-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35715710/\">https://pubmed.ncbi.nlm.nih.gov/35715710</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C10AB05;
